These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 15280513

  • 1. CD40 ligand: a novel target in the fight against cardiovascular disease.
    Vishnevetsky D, Kiyanista VA, Gandhi PJ.
    Ann Pharmacother; 2004 Sep; 38(9):1500-8. PubMed ID: 15280513
    [Abstract] [Full Text] [Related]

  • 2. Anti-inflammatory effects of clopidogrel intake in renal transplant patients: effects on platelet-leukocyte interactions, platelet CD40 ligand expression, and proinflammatory biomarkers.
    Graff J, Harder S, Wahl O, Scheuermann EH, Gossmann J.
    Clin Pharmacol Ther; 2005 Nov; 78(5):468-76. PubMed ID: 16321613
    [Abstract] [Full Text] [Related]

  • 3. Randomized comparison of the effects of ASA plus clopidogrel versus ASA alone on early platelet activation in acute coronary syndromes with elevated high-sensitivity C-reactive protein and soluble CD40 ligand levels.
    Vavuranakis M, Latsios G, Aggelis D, Bosinakou I, Karambelas I, Tousoulis D, Toutouzas K, Stefanadis C.
    Clin Ther; 2006 Jun; 28(6):860-71. PubMed ID: 16860169
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Plasma, serum, and platelet expression of CD40 ligand in adults with cardiovascular disease.
    Mason PJ, Chakrabarti S, Albers AA, Rex S, Vitseva O, Varghese S, Freedman JE.
    Am J Cardiol; 2005 Nov 15; 96(10):1365-9. PubMed ID: 16275179
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Elevated plasma levels of the atherogenic mediator soluble CD40 ligand in diabetic patients: a novel target of thiazolidinediones.
    Varo N, Vicent D, Libby P, Nuzzo R, Calle-Pascual AL, Bernal MR, Fernández-Cruz A, Veves A, Jarolim P, Varo JJ, Goldfine A, Horton E, Schönbeck U.
    Circulation; 2003 Jun 03; 107(21):2664-9. PubMed ID: 12742991
    [Abstract] [Full Text] [Related]

  • 15. Soluble CD40 Ligand in Aspirin-Treated Patients Undergoing Cardiac Catheterization.
    Gremmel T, Frelinger AL, Michelson AD.
    PLoS One; 2015 Jun 03; 10(8):e0134599. PubMed ID: 26237513
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The CD40-CD40L system in cardiovascular disease.
    Pamukcu B, Lip GY, Snezhitskiy V, Shantsila E.
    Ann Med; 2011 Aug 03; 43(5):331-40. PubMed ID: 21244217
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Homocysteine modulates the CD40/CD40L system.
    Prontera C, Martelli N, Evangelista V, D'Urbano E, Manarini S, Recchiuti A, Dragani A, Passeri C, Davì G, Romano M.
    J Am Coll Cardiol; 2007 Jun 05; 49(22):2182-90. PubMed ID: 17543638
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.